CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer. Rahman R, Rahaman MH, Hanson AR, Choo N, et al. Br J Cancer 2024 Aug 8. doi: 10.1038/s41416-024-02810.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rahman R, Rahaman MH, Hanson AR, Choo N, et al. CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer. Br J Cancer 2024 Aug 8. doi: 10.1038/s41416-024-02810.
PMID: 39117800